It seems that Rogaine is not the only effective cure for baldness anymore. Researchers may have the cure for male baldness in the works. Thanks to a team of scientists from Yale University, a man has built back his confidence and reclaims the hair that he has been missing. The bald volunteer is the first to go through the procedure and ended up with a full head of hair. What was originally meant to help with the symptoms of arthritis is possibly a new cure for baldness.
Patient Kyle Rhodes was suffering from the autoimmune disease alopecia and has coped with the symptoms by enlisting in the Yale University treatment. Diagnosed with alopecia acreata at the age of 2, Rhodes’ hair began to fall out in clumps. By 18, the unfortunate patient was completely bald. Alopecia universalis/acreata is a disease that causes the body to attack hair follicles, the result ends in the thinning and balding of those afflicted. His dermatologist, Dr. Brett King of Yale University, decided to enlist Rhodes in a new clinical trial for Xeljanz, to cope with the autoimmune disorder rheumatoid arthritis. Fortunately for Rhodes, the treatment was a success.
Dr. King hopes that the drug will also work for those suffering from the acute immunodeficiency disease. With further testing, doctors hope that Xeljanz was discovered as an alternative cure to baldness and to the devastating disease. Although other patients have died from tuberculosis infections or rise in cancer risks while taking Xeljanz, Rhodes is one of the fortunate candidates that made it through and has a chance to start off life again with new long locks of hair.
Commonly in tablet form, King hopes to convert Xeljanz into a cream that can be used topically to cure baldness in patients. With the transition from pill to cream, the drug will have minimal side effects on the body and attack the problem right at the source. Fortunately for Rhodes, he has stated that he has had no side effects from taking the pill and has already tried drugs that are a lot worse on the body than Xeljanz. This change will certainly be welcomed by the general public and is another example of how one drug can be used to treat other afflictions.
Although Rhodes has discovered a cure for his affliction, the treatment will not help those that suffer from male pattern baldness. The drug is only used to treat autoimmune deficiency disorders and not those that are afflicted with hereditary disorders that have nothing to do with the immune system. The possible cure still needs to go through multiple testing trials before introduced to the general public. Even with its curative properties, it can still run up to $25,000 a year with insurance. Though it is not clear whether someone suffering from alopecia will have to take the drug for life, Rhodes is one lucky patient that has overcome the obstacles of baldness and discovered a cure that led him to tell his story. Rhodes is not afraid of the drug or the possible side effects, but continues to take it because it helps with his symptoms of psoriasis.
By Tyler Cole
Daily Digest News